Phio Pharmaceuticals Valuation
| PHIO Stock | USD 0.86 0.07 7.53% |
Today, the company appears to be undervalued. Phio Pharmaceuticals Corp holds a recent Real Value of $4.14 per share. The prevailing price of the company is $0.86. Our model determines the value of Phio Pharmaceuticals Corp from analyzing the company fundamentals such as Return On Equity of -1.02, shares outstanding of 11.04 M, and Shares Owned By Institutions of 18.43 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Phio Pharmaceuticals' valuation include:
Price Book 1.0107 | Enterprise Value | Enterprise Value Ebitda 0.6124 | Price Sales 48.0082 | Forward PE 0.3064 |
Undervalued
Today
Please note that Phio Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Phio Pharmaceuticals Corp is based on 3 months time horizon. Increasing Phio Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Phio Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Phio Stock. However, Phio Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.86 | Real 4.14 | Target 14.0 | Hype 0.84 | Naive 0.79 |
The intrinsic value of Phio Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Phio Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Phio Pharmaceuticals Corp helps investors to forecast how Phio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Phio Pharmaceuticals more accurately as focusing exclusively on Phio Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Phio Pharmaceuticals' intrinsic value based on its ongoing forecasts of Phio Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Phio Pharmaceuticals' closest peers.
Phio Pharmaceuticals Cash |
|
Phio Pharmaceuticals Total Value Analysis
Phio Pharmaceuticals Corp is at this time forecasted to have valuation of 1.49 M with market capitalization of 15.79 M, debt of 1.01 M, and cash on hands of 18.02 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Phio Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.49 M | 15.79 M | 1.01 M | 18.02 M |
Phio Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Phio is to check how much profit was generated for every dollar of assets it reports. Phio Pharmaceuticals holds a negative application of assets of -0.56 pct., losing $0.005607 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Phio Pharmaceuticals Corp shows how discouraging it operates for each dollar spent on its assets.Phio Pharmaceuticals Profitability Analysis
Based on Phio Pharmaceuticals' profitability indicators, Phio Pharmaceuticals Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Phio Pharmaceuticals' ability to earn profits and add value for shareholders.Net Loss | First Reported 2011-03-31 | Previous Quarter -2.2 M | Current Value -2.4 M | Quarterly Volatility 1.8 M |
For Phio Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Phio Pharmaceuticals Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Phio Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Phio Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Phio Pharmaceuticals over time as well as its relative position and ranking within its peers.
Phio Pharmaceuticals Earnings per Share Projection vs Actual
By analyzing Phio Pharmaceuticals' earnings estimates, investors can diagnose different trends across Phio Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Phio Pharmaceuticals Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Phio Pharmaceuticals Ownership Allocation
The market capitalization of Phio Pharmaceuticals Corp is $15.79 Million. Phio Pharmaceuticals holds 7.58 pct. of its outstanding shares held by insiders and 18.43 pct. owned by third-party entities. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Phio Pharmaceuticals Profitability Analysis
Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (3.59 M).About Phio Pharmaceuticals Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Phio Pharmaceuticals Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Phio Pharmaceuticals Corp based exclusively on its fundamental and basic technical indicators. By analyzing Phio Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Phio Pharmaceuticals's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Phio Pharmaceuticals. We calculate exposure to Phio Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Phio Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -4.2 M | -4.4 M | |
| Pretax Profit Margin | (487.82) | (512.21) | |
| Operating Profit Margin | (492.15) | (516.75) | |
| Net Loss | (487.82) | (512.21) | |
| Gross Profit Margin | (27.31) | (28.68) |
Phio Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 7.9 M | |
| Forward Price Earnings | 0.3064 |
Phio Pharmaceuticals Current Valuation Indicators
Phio Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Phio Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Phio Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Phio Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Phio Pharmaceuticals' worth.When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Biotechnology sector continue expanding? Could Phio diversify its offerings? Factors like these will boost the valuation of Phio Pharmaceuticals. Anticipated expansion of Phio directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phio Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Phio Pharmaceuticals Corp's market price often diverges from its book value, the accounting figure shown on Phio's balance sheet. Smart investors calculate Phio Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Phio Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Phio Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phio Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.